DK1788876T3 - Fremgangsmåde til fremstilling af imidazolforbindelser og salte og pseudopolymorfer deraf - Google Patents

Fremgangsmåde til fremstilling af imidazolforbindelser og salte og pseudopolymorfer deraf

Info

Publication number
DK1788876T3
DK1788876T3 DK05786030T DK05786030T DK1788876T3 DK 1788876 T3 DK1788876 T3 DK 1788876T3 DK 05786030 T DK05786030 T DK 05786030T DK 05786030 T DK05786030 T DK 05786030T DK 1788876 T3 DK1788876 T3 DK 1788876T3
Authority
DK
Denmark
Prior art keywords
pseudopolymorphs
salts
preparation
imidazole compounds
imidazole
Prior art date
Application number
DK05786030T
Other languages
English (en)
Inventor
Ines Petschen
Xavier Camps
Juan Sallares
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35295386&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1788876(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferrer Int filed Critical Ferrer Int
Application granted granted Critical
Publication of DK1788876T3 publication Critical patent/DK1788876T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/501,3-Diazoles; Hydrogenated 1,3-diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Dentistry (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Agronomy & Crop Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK05786030T 2004-09-13 2005-09-13 Fremgangsmåde til fremstilling af imidazolforbindelser og salte og pseudopolymorfer deraf DK1788876T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200402183A ES2249991B1 (es) 2004-09-13 2004-09-13 Procedimiento de fabricacion de compuestos imidazolicos, sus sales y sus pseudopolimorfos.
PCT/EP2005/009825 WO2006029812A1 (en) 2004-09-13 2005-09-13 Method for manufacturing imidazole compounds and salts and pseudopolymorphs thereof

Publications (1)

Publication Number Publication Date
DK1788876T3 true DK1788876T3 (da) 2009-08-31

Family

ID=35295386

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05786030T DK1788876T3 (da) 2004-09-13 2005-09-13 Fremgangsmåde til fremstilling af imidazolforbindelser og salte og pseudopolymorfer deraf

Country Status (24)

Country Link
US (1) US7829726B2 (da)
EP (1) EP1788876B1 (da)
JP (1) JP4866355B2 (da)
KR (1) KR100861436B1 (da)
CN (1) CN100579966C (da)
AR (1) AR053093A1 (da)
AT (1) ATE431076T1 (da)
AU (1) AU2005284331B2 (da)
BR (1) BRPI0515254A (da)
CA (1) CA2577253C (da)
DE (1) DE602005014491D1 (da)
DK (1) DK1788876T3 (da)
ES (1) ES2249991B1 (da)
HK (1) HK1104765A1 (da)
MX (1) MX2007002924A (da)
NO (1) NO337950B1 (da)
PA (1) PA8645401A1 (da)
PE (1) PE20060690A1 (da)
PL (1) PL1788876T3 (da)
PT (1) PT1788876E (da)
RU (1) RU2357965C2 (da)
TW (1) TWI357813B (da)
UY (1) UY29116A1 (da)
WO (1) WO2006029812A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009326091A1 (en) * 2008-12-09 2010-06-17 Ferrer Internacional, S.A. Polymorph II of an antifungal compound
US10437922B2 (en) * 2015-12-03 2019-10-08 Workday, Inc. Spreadsheet with unit based conversions
CN113501815A (zh) * 2021-07-30 2021-10-15 海南海神同洲制药有限公司 一种硝酸舍他康唑晶型的制备方法
CN113501814A (zh) * 2021-07-30 2021-10-15 海南海神同洲制药有限公司 一种硝酸舍他康唑的纯化方法
CN113816947A (zh) * 2021-08-25 2021-12-21 海南海神同洲制药有限公司 一种硝酸舍他康唑的重结晶方法
CN113735843B (zh) * 2021-09-07 2023-05-26 海南海神同洲制药有限公司 一种低熔点硝酸舍他康唑的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8504779A1 (es) 1984-02-02 1985-05-01 Ferrer Int Procedimiento de obtencion de nuevos derivados de 1h-imidazol
CA1250586A (en) 1984-02-02 1989-02-28 Manuel Raga 1h-imidazole derivatives and process for their production
US5135943A (en) * 1984-02-02 1992-08-04 Ferrer Internacional S.A. 1H-imidazole derivative compounds and pharmaceutical compositions containing the same
DE69503364T2 (de) * 1995-01-04 1999-04-15 Ferrer Internacional S.A., Barcelona Verfahren zur herstellung von polymorphe b und c von 1-(2,4-dichloro-beta-((7-chloro-benzo(b)thien-3-yl)methoxy)phenethyl) imidazol-mononitrat
CN1191250C (zh) * 2001-09-26 2005-03-02 河北省药物研究所 一种硝酸舍他康唑的合成方法
ES2203316B1 (es) * 2002-02-11 2005-03-01 Ferrer Internacional, S.A. R-(-)-1-(2-(7-cloro-benzo(b)tiofen-3-il-metoxi)-2-(2,4-dicloro-fenil)-etil)1h-imidazol.

Also Published As

Publication number Publication date
WO2006029812A1 (en) 2006-03-23
AU2005284331B2 (en) 2010-12-23
JP4866355B2 (ja) 2012-02-01
KR100861436B1 (ko) 2008-10-02
CN100579966C (zh) 2010-01-13
JP2008512422A (ja) 2008-04-24
ATE431076T1 (de) 2009-05-15
CN101022727A (zh) 2007-08-22
ES2249991B1 (es) 2007-03-01
BRPI0515254A (pt) 2008-07-15
MX2007002924A (es) 2007-06-15
EP1788876A1 (en) 2007-05-30
PL1788876T3 (pl) 2009-11-30
UY29116A1 (es) 2005-11-30
AU2005284331A1 (en) 2006-03-23
TW200618799A (en) 2006-06-16
US7829726B2 (en) 2010-11-09
ES2249991A1 (es) 2006-04-01
PA8645401A1 (es) 2006-06-02
RU2007113922A (ru) 2008-10-20
EP1788876B1 (en) 2009-05-13
PE20060690A1 (es) 2006-07-11
US20090005573A1 (en) 2009-01-01
HK1104765A1 (en) 2008-01-25
DE602005014491D1 (de) 2009-06-25
PT1788876E (pt) 2009-08-17
CA2577253C (en) 2012-11-20
NO20071818L (no) 2007-05-04
TWI357813B (en) 2012-02-11
AR053093A1 (es) 2007-04-25
RU2357965C2 (ru) 2009-06-10
KR20070049663A (ko) 2007-05-11
CA2577253A1 (en) 2006-03-23
NO337950B1 (no) 2016-07-18

Similar Documents

Publication Publication Date Title
DK1828164T3 (da) Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider
DK1778668T3 (da) Fremgangsmåde til fremstilling af dihydropteridion
DK1830850T3 (da) Quinolin-derivater til behandling af latent tuberkulose
DK1805312T3 (da) Fremgangsmåder og midler til fremstilling af hyaluronan
DK1701941T3 (da) Forbindelser til behandling af sygdomme med celleproliferation
DK2508521T4 (da) Dimaleat af en aminocrotonylforbindelse og fremgangsmåde til fremstilling deraf
DK2101819T3 (da) Fremgangsmåder, sammensætninger og kits til behandling af smerte og pruritis
DK1781604T3 (da) Bis(thio-hydrazid-amid)-salte til behandling af cancere
DK1765391T3 (da) Bakterielle præparater til behandlingen af cancer
DK1877232T3 (da) Fremgangsmåde til behandling af træoverflader
DK2068874T3 (da) Fremgangsmåder til behandling af multiple myelom med anvendelse af kombinationsterapier baseret på anti-cs1 antistoffer
DK1611108T3 (da) Fremgangsmåde til fremstilling af telmisartan
DK2086944T3 (da) Fremgangsmåde til fremstilling af difluormethylpyrazolylcarboxylater
DK1813678T3 (da) Fremgangsmåde til fremstilling af glycogen
DK3403657T3 (da) Anvendelse af oligouronater til behandling af slimhyperviskositet
DK1701944T3 (da) 2-(amino-substituerede)-4-aryl-pyramidiner og relaterede forbindelser til behandling af inflammationssygdomme
DK1756049T3 (da) Fremgangsmåde til fremstilling af 1,4-diphenylazetidinon-derivater
DK1988090T3 (da) Imidazol-5-carboxylsyrederivater, fremgangsmåder til fremstilling af disse og anvendelse deraf
DK1546122T3 (da) Fremgangsmåde til fremstilling af valsartan
DK1831223T3 (da) Fremgangsmåde til fremstilling af L-biopterin
DK1963251T3 (da) Fremgangsmåde til fremstilling af aminer
DK2146742T3 (da) Cellelinjer, sammensætninger omfattende disse til behandling af melanomer, fremgangsmåder til at fremstille sammensætningerne og behandlingsmetoder
DK1814555T3 (da) S-mirtazapin til behandling af hedeture
DK2215050T3 (da) Fremgangsmåde til fremstilling af 2-hydroxy-5-phenylalkylaminobenzoesyrederivater og salte deraf
DK1788876T3 (da) Fremgangsmåde til fremstilling af imidazolforbindelser og salte og pseudopolymorfer deraf